Oncolytic Herpes Simplex Virus-Based Therapies for Cancer

With the increased worldwide burden of cancer, including aggressive and resistant cancers, oncolytic virotherapy has emerged as a viable therapeutic option. Oncolytic herpes simplex virus (oHSV) can be genetically engineered to target cancer cells while sparing normal cells. This leads to the direct...

Full description

Bibliographic Details

Published in:	Cells
Main Authors:	Norah Aldrak, Sarah Alsaab, Aliyah Algethami, Deepak Bhere, Hiroaki Wakimoto, Khalid Shah, Mohammad N. Alomary, Nada Zaidan
Format:	Article
Language:	English
Published:	MDPI AG 2021-06-01
Subjects:	oncolytic herpes simplex virus (oHSV) virotherapy immunotherapy cancer
Online Access:	https://www.mdpi.com/2073-4409/10/6/1541